Status:
UNKNOWN
Concomitant CC and E2 Versus CC Alone in Ovulation Induction
Lead Sponsor:
Maher elesawi kamel elesawi
Conditions:
Infertility
Anovulation
Eligibility:
FEMALE
20-39 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the effect of concomitant administration of estradiol during use of clomiphene citrate (CC) for induction of ovulation in infertile women.
Detailed Description
Women will be randomly divided into two groups; CC-E2 group and CC group. Women in the CC-E2 group will receive CC (100 mg/day for 5 consecutive days from day 2 of cycle) and estradiol (2 mg/day for 5...
Eligibility Criteria
Inclusion
- Infertile women with eugonadotrophic anovulation/oligoovulation.
- Unexplained infertility.
Exclusion
- Age \< 20 or \> 35 years.
- Body mass index (BMI) \< 18.5 kg/m2 or \> 25 kg/m2.
- Presence of any infertility factor other than anovulation/oligoovulation.
- Previous history of ovarian surgery or surgical removal of one ovary.
- Previous exposure to cytotoxic drugs or pelvic irradiation.
- Metabolic or hormonal abnormalities.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2018
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT02186782
Start Date
June 1 2014
End Date
August 1 2018
Last Update
March 22 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Obstetrics and Gynecology Department in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35111
2
Private practice settings
Al Mansurah, Dakahlia Governorate, Egypt
3
Private practice settings
Mīt Ghamr, Dakahlia Governorate, Egypt